Views are my own
Sydney, New South Wales
Joined April 2010
- Tweets698
- Following187
- Followers144
- Likes1.2K
Júlia Bier retweeted
Human PIK3R1 mutations disrupt lymphocyte differentiation to cause activated PI3Kδ syndrome 2, say Tina Nguyen, Anthony Lau, @bier_julia, @stutangye @Tangye_Lab @ElissaDeenick @DeenickLab & colleagues @GarvanInstitute: bit.ly/42rfmlB
#Immunodeficiency
Júlia Bier retweeted
Out today in @JExpMed our @DeenickLab paper comparing APDS1 and APDS2. We show while these two conditions are similar, not all PI3K dysregulation is the same. Great collab with @stutangye and 3 great PhD students @bier_julia, Tina Nguyen and Anthony Lau bit.ly/42rfmlB
This better be one of the best titles ever 😂
Our spotlight @TrendsImmuno by @ramadhenni on really interesting work by @MauroGaya et al on lung resident Bmem that are primed to differentiate into plasma cells in the local defense against reinfection by respiratory viruses like 'Flu and SARS-CoV-2.
cell.com/trends/immunology/f…
Júlia Bier retweeted
It's official! Thx to @Cancer_Research the ACRF INCITe Centre launched @GarvanInstitute with help from @spenderallegra, @_PiaMiranda & friends. To explore the dark space of tumours to improve cancer immunotherapy we are looking for new post-docs to helm the new spaceships! DM me!
The ACRF Centre for Intravital Imaging of Niches for Cancer Immune Therapy (INCITe) at Sydney’s @GarvanInstitute has officially launched. This game-changing program was enabled by a $3 million grant awarded by ACRF to Garvan Institute in 2020. Learn more: bit.ly/3uy3KOz
Júlia Bier retweeted
Thrilled to announce first PhD paper from David Cooper Fellow Dr Pei Dai @GarvanInstitute @UNSWMedicine @SVHSydney @CIRCA_genomics now online @GIMJournal! Diagnostic rate is <1 in 2 for clinical genomic testing. Should data be reanalysed? When? How? 1/n
tinyurl.com/4tkn5vnm
Today’s wrap up on a great conference #AAI2022 . Got great interest and feedback during my poster presentation following yesterday’s talk! These are the moments we realise how much we love science🤓 @DeenickLab @GarvanInstitute Thanks @ImmunologyAAI for supporting me to be here
So lucky to have had the chance to present my work @DeenickLab and to be part of such a great meeting. I also got the see Chris receiving this amazing award. So proud to be part of @GarvanInstitute . Thanks @ImmunologyAAI for supporting me and @ElissaDeenick
Glad that I could be there to see Chris get his award and hear him share about his journey in understanding how B cell tolerance is controlled. @GarvanInstitute Thanks to @ImmunologyAAI for gettting @bier_julia and me here.
Júlia Bier retweeted
The Precision Immunology program @GarvanInstitute is hiring! @ElissaDeenick and I are looking for talent to work with Dr Robert Brink and the Genomic Engineering Group to deliver therapeutic mRNA in mouse models of disease. Link below. Please RT!
tinyurl.com/bdfcef32
Great stuff! So lucky to have heard this first hand at lab meeting! Well done @LabPhan @GarvanInstitute
1/ We are live @biorxiv_immuno! Clonal dynamics of SARS-CoV-2-specific T cells in children and adults. Amazing collaboration between @GarvanInstitute @G_WCentre @UNSWMedicine @SVHSydney @SCHNKids @Sydney_Uni @KirbyInstitute @kids_research @Griffith_Uni.
tinyurl.com/2p8dubep
Happy to have this review published with @ElissaDeenick in which we tear apart a lot of the problems behind PI3K dysregulation, including the work done at @DeenickLab @TangyeMaLab and others
Excited to have this article that @bier_julia and I wrote online - breaks down the ways dysregulated PI3K can drive antibody mediated autoimmunity onlinelibrary.wiley.com/doi/…
Júlia Bier retweeted
Great to see this finally out in @iScience_CP: Early expansion of CD38+ICOS+ GC Tfh in draining lymph nodes during influenza vaccination immune response. Congrats @hannahrosielaw and @mezzam et al @KirbyInstitute and @UNSWMedicine!
cell.com/iscience/fulltext/S…
Júlia Bier retweeted
Postdocs, PhD students & Twitter-verse,
We will be hosting our October PDDC Education seminar on Tuesday 19th October at 10am.
Our presenter for this month will be Dr Tim Peters @GarvanInstitute
“Gene expressivism: "good" practice for bulk and single-cell RNA-Seq analysis” 🙏🤩
Júlia Bier retweeted
We are excited to be hosting @aemonten Editor @CurrentProtocol for our next Educational Seminar on Sept 7th at 10:00 am🤩. Thanks for accepting our invitation and we look forward to talking to you in a very relaxed Q&A format. Bring your coffee/tea and have a good virtual time!
Júlia Bier retweeted
Today we highlight @bier_julia 🇧🇷 who works on lymphoma and primary immunodeficiencies related to lymphocyte biology at @GarvanInstitute @DeenickLab She loves her science and living in Sydney! Read the 10 Q&A to know more about Dr Julia (e.g., Brazilian dancing?!).
Júlia Bier retweeted
What's more dangerous than getting the AstraZeneca vaccine?
Everything in life carries some degree of risk. It's up to us to choose whether the benefits outweigh those risks. #FightingCoV2
ALT If you choose to get the AstraZeneca vaccine, your risk of death from TTS is 1 in a million and your risk of getting TTS at all is less than 30 in a million. But how does that compare? Risk of death from a general anaesthetic is 18 in a million. Risk of death from accidental poisoning is 55 in a million. Risk of being struck by lightning is 2 in a million. Risk of death due to rock climbing is 3 in a million. Risk of death from giving birth is 67 in a million. Risk of death due to daily aspirin is 100 in a million. 1 in a million is really rare. When considering vaccination against COVID-19, it's important to remember the proven benefits vastly outweigh the really rare risks. TTS is a rare condition reported in some people who have received adenoviral vector COVID-19 vaccines. TTS is different from other more common blood clotting conditions as it is triggered by an immune response. Having a history of blood clots like DVT, does not increase your risk of TTS due to the vaccine.
Júlia Bier retweeted
Today’s the day to help the LSU community. Get your vaccine: lsu.edu/roadmap/vaccines/
Super proud of @clacyoung ! Amazing review on GC recently published at @ImmunityCP
New in @ImmunityCP by @clacyoung in Brink lab @GarvanInstitute. 20 years after PhD my old mentor still schooling me on the GC! We know so little. Even more critical in COVID era that we learn more to get the most out of the GC to boost immunity to VoC.
cell.com/immunity/fulltext/S…
Júlia Bier retweeted
Congratulations to Garvan team @LabPhan @josealquicirah and @drjosephpowell for their paper now out in @ClinTransImmuno! Using single-cell sequencing, they provide new insights into how immune cells change during COVID-19 infection: onlinelibrary.wiley.com/doi/…
Júlia Bier retweeted
We look forward to this talk so much! Our second Educational Seminar will be all about Preprints. Thanks for accepting our invitation Dr Helen. 🙏😁 Great to launch ourselves into Twitterverse with this initiative, please RT and expand the voice (& follow us for + info)! 🔁
Looking forward to talking about preprinting and preLights at the @PddcSydney meeting on the 5 July. Thank you @osvaldoics for the invite!